Abstract
Lung transplantation, when used as the ultimate treatment for selected patients suffering from any form of benign, end-stage lung disease, is limited by the number of suitable brain-dead donors [1]. Various strategies have been applied to increase the potential lung donor pool, including living lobar transplantation, split lung transplantation, the use of extended criteria donors [2], as well as donors after cardiac death, or so called nonheart-beating donors [3].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
